Skip to main content

Table 1 Baseline characteristics

From: Cardiovascular magnetic resonance can detect occult anthracycline cardiotoxicity in adolescents and young adults cancer survivors with normal ejection fraction

CHARACTERISTICS PATIENTS CONTROLS p
Age, years 18 ± 2 [12-21] 19 ± 3 [12-24] 0.109
Gender, n 11 males; 9 females 12 males; 8 females 0.749
LV ejection fraction [LVEF (%)] 59 ± 3.5 61 ± 4.2 0.057
LV end-diastolic volume indexed [LVEDVi (mL/m2)] 85 ± 16.5 85 ± 14.1 0.975
LV end-systolic volume [LVESVi (mL/m2)] 35 ± 9.5 35 ± 9.1 0.946
Global circumferential strain (GCs) -14.0 ± 3.6 -16.4 ± 3.5 0.041
Global radial strain (GRs) 17.2 ± 6.4 30.7 ± 6.9 <0.001
Global circumferential strain rate [GCSr (syst)] -1.25 ± 0.26 -1.58 ± 0.41 0.005
Global radial strain rate peak systole [GCRSr (syst)] 0.86 ± 0.21 2.44 ± 0.5 <0.001
Global circumferential strain rate early diastole [GCSr (diast)] 1.49 ± 0.41 1.85 ± 0.52 0.022
Global radial strain rate early diastole [GRSr (diast)] -1.61 ± 0.38 -2.21 ± 0.61 0.001
Native T1 (mid septum, ms) 1004 ± 70.6 966 ± 30.6 0.035
LA ejection fraction total (%) 66.9 ± 8.3 67.9 ± 7.8 0.692
LA conduit function (%) 41.2 ± 15.1 41.5 ± 10.6 0.928
LA booster pump function (%) 42.3 ± 9.1 44.5 ± 10.8 0.682
LA total strain (εs) 30.6 ± 8.6 30.7 ± 7.4 0.967
LA passive strain (εe) 24.1 ± 6.4 23.3 ± 5.2 0.638
LA active strain (εa) 6.5 ± 3.5 7.5 ± 3.6 0.400
LA peak positive strain rate (SRs) 1.2 ± 0.3 1.3 ± 0.4 0.430
LA peak early negative strain rate (SRe) -1.7 ± 0.4 1.7 ± 0.4 0.941
LA peak late negative strain rate (SRa) -0.9 ± 0.3 -1.0 ± 0.3 0.148
Pulse wave velocity [PWV (m/s)] 4.605 ± 0.51 3.742 ± 0.23 0.019